These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25019089)

  • 1. Development of dual inhibitors against Alzheimer's disease using fragment-based QSAR and molecular docking.
    Goyal M; Dhanjal JK; Goyal S; Tyagi C; Hamid R; Grover A
    Biomed Res Int; 2014; 2014():979606. PubMed ID: 25019089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of embelin, a 3-undecyl-1,4-benzoquinone from Embelia ribes as a multitargeted anti-Alzheimer agent.
    Nuthakki VK; Sharma A; Kumar A; Bharate SB
    Drug Dev Res; 2019 Aug; 80(5):655-665. PubMed ID: 31050027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents.
    Galdeano C; Viayna E; Arroyo P; Bidon-Chanal A; Blas JR; Muñoz-Torrero D; Luque FJ
    Curr Pharm Des; 2010; 16(25):2818-36. PubMed ID: 20698824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of 1,4-dihydropyridine derivatives as BACE-1 inhibitors.
    Choi SJ; Cho JH; Im I; Lee SD; Jang JY; Oh YM; Jung YK; Jeon ES; Kim YC
    Eur J Med Chem; 2010 Jun; 45(6):2578-90. PubMed ID: 20303626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Silico Docking and In Vitro Approaches towards BACE1 and Cholinesterases Inhibitory Effect of Citrus Flavanones.
    Lee S; Youn K; Lim G; Lee J; Jun M
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29932100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of Alzheimer's BACE-1 with 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridine structure.
    Miri R; Firuzi O; Razzaghi-Asl N; Javidnia K; Edraki N
    Arch Pharm Res; 2015 Apr; 38(4):456-69. PubMed ID: 24771353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multitarget Approach to Drug Candidates against Alzheimer's Disease Related to AChE, SERT, BACE1 and GSK3β Protein Targets.
    Ivanova L; Karelson M; Dobchev DA
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32316402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic Simulation, Docking and DFT Studies Applied to a Set of Anti-Acetylcholinesterase Inhibitors in the enzyme β-Secretase (BACE-1): An Important Therapeutic Target in Alzheimer`s disease.
    Silva-Junior EF; Barcellos Franca PH; Quintans-Junior LJ; Mendonca-Junior FJB; Scotti L; Scotti MT; de Aquino TM; de Araujo-Junior JX
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):266-274. PubMed ID: 28382866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking, molecular dynamics, binding energy-MM-PBSA studies of naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3β.
    Kumar A; Srivastava G; Negi AS; Sharma A
    J Biomol Struct Dyn; 2019 Feb; 37(2):275-290. PubMed ID: 29310523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
    Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM
    Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
    Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
    J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, In Silico and In Vitro Evaluation of Some Flavone Derivatives for Acetylcholinesterase and BACE-1 Inhibitory Activity.
    Tran TS; Tran TD; Tran TH; Mai TT; Nguyen NL; Thai KM; Le MT
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32899576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB; Aguan K; Mitra S; Bhattacharjee A
    J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.
    Gabr MT; Abdel-Raziq MS
    Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the active mechanism of β-secretase inhibitors by molecular simulations.
    Tian YL; Lv M; Li JJ; Xu T; Zhai HL; Zhang XY
    Eur J Pharm Sci; 2015 Aug; 76():138-48. PubMed ID: 25965961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and molecular docking study of fish roe-derived peptides as potent BACE 1, AChE, and BChE inhibitors.
    Yu Z; Ji H; Shen J; Kan R; Zhao W; Li J; Ding L; Liu J
    Food Funct; 2020 Jul; 11(7):6643-6651. PubMed ID: 32656560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive 3D-QSAR and binding mode of BACE-1 inhibitors using R-group search and molecular docking.
    Huang D; Liu Y; Shi B; Li Y; Wang G; Liang G
    J Mol Graph Model; 2013 Sep; 45():65-83. PubMed ID: 24004830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Docking and 3D Qsar Studies of C000000956 as a Potent Inhibitor of Bace-1.
    Joseph OA; Babatomiwa K; Niyi A; Olaposi O; Olumide I
    Drug Res (Stuttg); 2019 Aug; 69(8):451-457. PubMed ID: 30780168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of Curcumin and Flavonoid Derivatives with Acetylcholinesterase and Beta-Secretase Inhibitory Activities Using in Silico Approaches.
    Tran TS; Le MT; Tran TD; Tran TH; Thai KM
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32785161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer's disease.
    Kumar A; Srivastava G; Srivastava S; Verma S; Negi AS; Sharma A
    J Mol Model; 2017 Aug; 23(8):239. PubMed ID: 28741112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.